Clinical Trial Update: A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR) [Phase 3]

View source ↗

Summary

A Phase 3 safety and efficacy study of ciclesonide nasal aerosol in children 6-11 with seasonal allergic rhinitis completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Ciclesonide nasal aerosol (ciclesonide)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2014-05-15